Technology Issues: Continuous Glucose Monitoring, Insulin Pumps, and Closed Loop Control for Patients with Diabetes

Ravinder Jeet Kaur, Shafaq R. Rizvi, Yogish C. Kudva

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The best current treatment for patients with type 1 diabetes and severe insulin deficiency is a closed loop glucose insulin control (CLC) system. Glucose variability occurs due to severe deficiency in insulin secretion and the difficulty of replacing insulin without frequent glucose measurements that enable prompt change in insulin delivery. International committees have developed consensus about managing diabetes to achieve maximal time in target (TIR) on continuous glucose monitors (CGM). CGM allows for real-time assessment of glucose concentrations and trends by measuring interstitial glucose concentrations. The impact of CGM on diabetes management has been observed in both type 1 diabetes and type 2 diabetes and in select populations with diabetes. The optimal current treatment for patients with type 1 diabetes mellitus and severe insulin deficiency is a CLC system. Patients without CGM or insulin pump prior to study experienced the greatest improvement in TIR.

Original languageEnglish (US)
Title of host publicationClinical Dilemmas in Diabetes
Subtitle of host publicationSecond Edition
Publisherwiley
Pages115-123
Number of pages9
ISBN (Electronic)9781119603207
ISBN (Print)9781119603160
DOIs
StatePublished - Jan 1 2021

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Technology Issues: Continuous Glucose Monitoring, Insulin Pumps, and Closed Loop Control for Patients with Diabetes'. Together they form a unique fingerprint.

Cite this